STEPHEN J. HOFFMAN - 17 Jun 2021 Form 4 Insider Report for ACELRX PHARMACEUTICALS INC (ACRX)

Role
Director
Signature
/s/ Martha Adler, Attorney-In-Fact
Issuer symbol
ACRX
Transactions as of
17 Jun 2021
Net transactions value
$0
Form type
4
Filing time
17 Jun 2021, 17:25:55 UTC
Previous filing
07 Jun 2021
Next filing
29 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRX Common Stock Award $0 +10,000 +89% $0.000000 21,250 17 Jun 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACRX Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 17 Jun 2021 Common Stock 20,000 $1.41 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.
F3 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.